Latest News and Press Releases

RESEARCH TRIANGLE PARK, NC--(Marketwired - March 14, 2017) - Throughout the research and development process, third-party organizations have helped pharmaceutical, biotech and medical device teams to...

RESEARCH TRIANGLE PARK, NC--(Marketwired - March 07, 2017) - A new study of early-stage product development teams found that, on average, R&D comprises 64% of the internal clients that surveyed...

RESEARCH TRIANGLE PARK, NC--(Marketwired - March 06, 2017) - Cutting Edge Information is proud to be partnering with SMi Group, a global event-production company that specializes in creating and...

RESEARCH TRIANGLE PARK, NC--(Marketwired - March 02, 2017) - Sixty one percent of surveyed clinical trial teams favor traditional randomized controlled trials (RCTs) over other interventional study...

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 28, 2017) - Roughly 70% of life science firms have altered their medical communications with patients in response to newer technologies, such as...

RESEARCH TRIANGLE PARK, NC and DURHAM, NC--(Marketwired - February 22, 2017) - A study published by Cutting Edge Information found that 89% of surveyed drug company executives did not distinguish...

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 21, 2017) - Nearly one-third of surveyed pharmaceutical companies look to fair-market value (FMV) budget as one their most important criteria for...

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 16, 2017) - Sixty five percent of surveyed medical device companies report using a 501(k) clearance pathway for Class 2 devices, and 50% trend...

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 15, 2017) - Global pharmaceutical businesses are the most likely to involve multiple functions in postmarketing, or Phase 4, study planning. A...

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 14, 2017) - Although adaptive design clinical trials are a trending practice for developing new drugs, pharmaceutical companies still pursue plenty...